Fibromyalgia and Migraine, Two Faces of the Same Mechanism

Serotonin as the Common Clue for Pathogenesis and Therapy
  • M. Nicolodi
  • F. Sicuteri
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 398)


In this study fibromyalgia sufferers were randomly administered a combination of monoamine -oxidase inhibitors (MAOIs) -A/B with 5-HTP, 5-HTP alone, MAOIs-A/B alone, or the tricyclic drug amitriptyline in order to compare the efficacy of these treatments. The benefits on the painful syndrome were assessed by using Visual Analogic Scale score rating from 0 to 4. The combination of MAOIs with 5-HTP significantly improved fibromyalgia syndrome as determined by Visual Analogic Scale whereas the other treatments yielded poorer benefits. No subject withdrew from the trial due to adverse effects, even if some sleep disturbances and mild stomach-ache were reported. The tolerability of the association MAOIs/5-HTP was good, although a transient cheese effect occurred in one of the patients treated with MAOIs as well as in a patient treated with the association MAOIs and 5-HTP. No one of these two cases was due to pharmacological dietetic mistake of the patient. In both the cases the transient hypertension was associated to very dramatic emotional events.

The benefits obtained by using the combination of MAOIs with 5-HTP can be explained with a treatment-induced enhancement of aminergic and serotonergic transmission. The recently shown high prevalence of migraine in the population of fibromyalgia sufferers, suggests a common ground shared by fibromyalgia and migraine. Migraine has been demonstrated to be characterized by a defect in the serotonergic and adrenergic systems. A parallel dramatic failure of serotonergic systems and a defect of adrenergic transmission have been evidenced to affect fibromyalgia sufferers too. Enhancing serotonergic analgesia while increasing adrenergically mediated analgesia seems to be an important tool in fibromyalgia. Treatment consisting with the association MAOIs/5-HTP is aimed at enhancing serotonergic/adrenergic transmission by inducing an up-regulation of serotonergic/adrenergic receptors and a simultaneous increase of serotonin levels in the central nervous system.


Visual Analogical Scale Quinolinic Acid International Headache Society Fibromyalgia Syndrome Kynurenic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bastos, S.B., de Almeida-Filho, N., Santana, V.S., 1993, Prevalence of headache as a symptom in an urban area of Salvador, Bahia. Arq Neuropsiquiatr, 51 (3): 307CrossRefGoogle Scholar
  2. Boulton, A. A., Juorrio, A.V., Peterson, I.A., 1990, Phenylethylamine in the CNS: effects ofmonoamine oxidase inhibiting drugs, deuterium substitution and lesions and its role in the neuromodulation of catecholaminergic neurotransmission. J Neural Trans29: 119Google Scholar
  3. Creese, I., Sibley, D.R., 1981, Receptor adaptations to centrally acting drugs. Ann Rev Pharmacol Toxicol21: 357CrossRefGoogle Scholar
  4. Cremata, V,Y Koe, B.K., 1966, Clinical pharmacological evaluation of p-chlorophenylalanine: a new serotonin-depleting agent. Clin Pharmacol Ther7: 768Google Scholar
  5. Curzon, G., 1979, Relationship between plasma, CSF and brain tryptophan. J Neural Transm15: 81Google Scholar
  6. De Montis, M.G., Olianas, M,C,. Mulas, G., Tagliamonte, A., 1977, Evidence that only free serum tryptophan exchanges with the brain. Phar Res Commun9 (2): 215CrossRefGoogle Scholar
  7. Foster, A.C., Vezzani, A.M., French, E.D., Schwarcz, R., 1984, Kynurenic acid blocks neurotoxicity and seizures in rats by the related brain metabolite quinolinic acid. Neurosci Lett48: 273CrossRefGoogle Scholar
  8. Handworker, H.O., 1993, Mechanisms of cutaneous and subcutaneous hyperalgesia, in “New Trends in Referred Pain and Hyperalgesia”, Vecchiet L, Albe-Fessard D, Lindblom U, eds, Elsevier, Amsterdam (1993)Google Scholar
  9. Heinonen, E.H., Lammintausta, R.A., 1991, A review of the pharmacology of selegiline. Acta Neurol Scand84 (136): 44CrossRefGoogle Scholar
  10. International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia1998, 8 (7)Google Scholar
  11. King, R., 1980, Pain and tryptophan. JNeurosurg53: 44CrossRefGoogle Scholar
  12. Koshikawa, F., Koshikawa, N., Stephenson, J.D., 1985, Effects of antidepressant drugs and cortical 5-HT2 receptors and wet-dog shakes in rats. Eur J Pharmacol118: 273CrossRefGoogle Scholar
  13. Lance, J.W ., 1992, Possible role of serotonin in the migraine syndrome, in: “Advances in Pain Research and Therapy”, Sicuteri F., Terenius L., Vecchiet L., Maggi CA.,eds, Raven Press, New YorkGoogle Scholar
  14. Mc Cain, G.A., 1990, Management of fibromyalgia syndrome. In: JR Fricton, A Essam (eds), Advances in Pain Research and Therapy, Vol 17, Raven Press, New YorkGoogle Scholar
  15. Moroni, F., Lombardi, G., Carla, V., Moneti G., 1984, The excitotoxin quinolinic acid is present and unevenly distributed in the rat brain. Brain Res295: 352CrossRefGoogle Scholar
  16. Munoz, M., Dumas, M., Boutros-Toni, F, Coquelle, D., Nicolas, A., Ndzanga, E„ Boa, F, Vallat, J.M., Dartigues, J.F., 1993, Prevalence of headache in a representative sample of the population in a French department (Haute-Vienne-Limousin) Headache33 (10) 521Google Scholar
  17. Nicolodi, M., Sicuteri, F., 1992, Central panalgia as an expression of systemic analgodeficiency. in: “Advances in Pain Research and Therapy”, F. Sicuteri, L Terenius, L Vecchiet, C A Maggi, eds, Raven Press, New YorkGoogle Scholar
  18. Panagiotidis, G., Stenstrom, A., Lundquist, I., 1993, Effects of adrenergic and cholinergic stimulation on islet monoamine oxidase activity and insulin secretion in the mouse. Eur J Pharmacol233 (3): 285CrossRefGoogle Scholar
  19. Perkins, M.N., Stone, T.W., 1982, An iontophoretic investigation of the actions of convulsant kynurenines and the interaction with endogenous excitant quinolinic acid. Brain Res247: 184CrossRefGoogle Scholar
  20. Rajiv, J., Welch, K.M.A., D’Andrea, G., 1989, Serotonergic hypofiinction in migraine: a synthesis of evidence based on platelet dense body dysfunction. Cephalalgia9: 18Google Scholar
  21. Seltzer, S., 1985, Pain relief by dietary manipulations and tryptophan supplements. J Endodontics11 (10): 449CrossRefGoogle Scholar
  22. Sicuteri, F., 1971, Pain syndrome in man following treatment with p-chlorophenylalanine. Pharmacol Res Comm3 (4): 401CrossRefGoogle Scholar
  23. Sicuteri, F., 1971, Pain syndrome in man following treatment with p-chlorophenylalanine. Pharmacol Res Comm3(4): 401CrossRefGoogle Scholar
  24. Sicuteri, F., Michelacci, S,. Franchi, G., 1962, Contributo alia caratterizzazione della farmacologia della reserpina sul sistema nervoso centrale. antagonismo di un bloccante adrenergico sul fenomeno dell’eccitazione paradossa da reserpina nel topo. Boll Soc Ital Biol Sper38 (8): 381Google Scholar
  25. Sicuteri, F., Fanciullacci, M., Del Bianco, PL., 1965, Variata reattivita alia 5-idrossitriptamina ed alia nor-adrenalina da anti monoamino ossidasici nell’ uomo. Boll Soc Ital Biol Sper41 (9): 467Google Scholar
  26. Sicuteri, F., Fanciullacci, M., Del Bianco, P.L., 1965, Variata reattivita alia 5-idrossitriptamina ed alia nor-adrenalina da anti monoamino ossidasici nell’ uomo. Boll Soc Ital Biol Sper41 (9): 467Google Scholar
  27. Sicuteri, F., Anselmi, B., Fanciullacci, M., 1974, The serotonin (5-HT) theory of migraine. Adv Neurol4: 383Google Scholar
  28. Sicuteri, F., Anselmi, B., Del Bianco, P.L., 1978, Systemic non organic central pain with decentralization super-sensitivity. Headache18: 133CrossRefGoogle Scholar
  29. Sicuteri, F., Nicolodi, M., Fusco, B.M., 1984, Abnormal sensitivity to agonists, antagonists and releasers, in: “Basic Mechanism of headache”, JOlesen, L Edvinnsson, eds, Elsevier, AmsterdamGoogle Scholar
  30. Sicuteri, F., Nicolodi, M., 1991, Serotonin: a “Sphynx” in migraine, in, “Headache and depression: serotonin pathways as a common clue”, Nappi G et al., eds, Raven Press, New YorkGoogle Scholar
  31. Simons, D ., 1990, Muscular pain syndromes, in: “Advances in Pain Research and Therapy”, JR Fricton, A Essam,eds, Raven Press, New YorkGoogle Scholar
  32. Wang, R.I.H., Wiesen, R.L., Treul, S., Stockdale, S., 1976, Brief anxiety rating test J Clin Pharmacol16 (2/3): 99 - 105Google Scholar
  33. Wolfe, F., Smythe, H.A., Yunus, M.B., 1990, The american college of rheumatology 1990 Criteria for the classification of fibromyalgia, report of the multicenter criteria committee. Arthritis Rheum33: 160CrossRefGoogle Scholar
  34. Zimmermann, M ., 1991, Pathophysiological mechanisms of fibromyalgia. Clin J Pain7(1): 8CrossRefGoogle Scholar
  35. Zung, WW . 1965 A self rating depression scale. Arch Gen Psychiatry12: 163–65Google Scholar

Copyright information

© Plenum Press, New York 1996

Authors and Affiliations

  • M. Nicolodi
    • 1
  • F. Sicuteri
    • 1
  1. 1.Interuniversity Centre of Neurochemistry and Clinical Pharmacology of Idiopathic Headache Florence UniversityFlorenceItaly

Personalised recommendations